BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 10570484)

  • 1. Activity-dependent changes in partial VAMP complexes during neurotransmitter release.
    Hua SY; Charlton MP
    Nat Neurosci; 1999 Dec; 2(12):1078-83. PubMed ID: 10570484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different VAMP/synaptobrevin complexes for spontaneous and evoked transmitter release at the crayfish neuromuscular junction.
    Hua SY; Raciborska DA; Trimble WS; Charlton MP
    J Neurophysiol; 1998 Dec; 80(6):3233-46. PubMed ID: 9862918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction.
    Raciborska DA; Trimble WS; Charlton MP
    Eur J Neurosci; 1998 Aug; 10(8):2617-28. PubMed ID: 9767392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gbetagamma acts at the C terminus of SNAP-25 to mediate presynaptic inhibition.
    Gerachshenko T; Blackmer T; Yoon EJ; Bartleson C; Hamm HE; Alford S
    Nat Neurosci; 2005 May; 8(5):597-605. PubMed ID: 15834421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct kinetic changes in neurotransmitter release after SNARE protein cleavage.
    Sakaba T; Stein A; Jahn R; Neher E
    Science; 2005 Jul; 309(5733):491-4. PubMed ID: 16020741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
    Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
    Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanism of action of tetanus toxin and botulinum neurotoxins].
    Poulain B
    Pathol Biol (Paris); 1994 Feb; 42(2):173-82. PubMed ID: 7916455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].
    Doussau F; Humeau Y; Vitiello F; Popoff MR; Poulain B
    J Soc Biol; 1999; 193(6):457-67. PubMed ID: 10783704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synaptophysin/synaptobrevin complex dissociates independently of neuroexocytosis.
    Reisinger C; Yelamanchili SV; Hinz B; Mitter D; Becher A; Bigalke H; Ahnert-Hilger G
    J Neurochem; 2004 Jul; 90(1):1-8. PubMed ID: 15198661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-terminal transmembrane region of synaptobrevin binds synaptophysin from adult synaptic vesicles.
    Yelamanchili SV; Reisinger C; Becher A; Sikorra S; Bigalke H; Binz T; Ahnert-Hilger G
    Eur J Cell Biol; 2005 Apr; 84(4):467-75. PubMed ID: 15900706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tetanus and botulinum toxins are zinc metallopeptidases: molecular mechanisms and inhibition of their neurotoxicity].
    Cornille F; Roques BP
    J Soc Biol; 1999; 193(6):509-16. PubMed ID: 10783709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
    Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterisation of tetanus and botulinum neurotoxins binding domains.
    Lalli G; Herreros J; Osborne SL; Montecucco C; Rossetto O; Schiavo G
    J Cell Sci; 1999 Aug; 112 ( Pt 16)():2715-24. PubMed ID: 10413679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroscience. A neuronal receptor for botulinum toxin.
    Jahn R
    Science; 2006 Apr; 312(5773):540-1. PubMed ID: 16645086
    [No Abstract]   [Full Text] [Related]  

  • 15. Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential.
    Meng J; Wang J; Lawrence G; Dolly JO
    J Cell Sci; 2007 Aug; 120(Pt 16):2864-74. PubMed ID: 17666428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proteins regulating neurotransmitter release of synaptic vesicles at nerve terminals].
    Cai Q; Lu PH; Sheng ZH
    Sheng Li Ke Xue Jin Zhan; 2003 Jan; 34(1):6-10. PubMed ID: 12778801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the light chain subcellular localization an important factor in botulinum toxin duration of action?
    Fernández-Salas E; Ho H; Garay P; Steward LE; Aoki KR
    Mov Disord; 2004 Mar; 19 Suppl 8():S23-34. PubMed ID: 15027051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular targets of botulinum toxin at the mammalian neuromuscular junction.
    Whelchel DD; Brehmer TM; Brooks PM; Darragh N; Coffield JA
    Mov Disord; 2004 Mar; 19 Suppl 8():S7-S16. PubMed ID: 15027049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca2+-dependent regulation of synaptic SNARE complex assembly via a calmodulin- and phospholipid-binding domain of synaptobrevin.
    Quetglas S; Leveque C; Miquelis R; Sato K; Seagar M
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9695-700. PubMed ID: 10944231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How botulinum and tetanus neurotoxins block neurotransmitter release.
    Humeau Y; Doussau F; Grant NJ; Poulain B
    Biochimie; 2000 May; 82(5):427-46. PubMed ID: 10865130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.